EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan

Aizhan Magazova, Yeldar Ashirbekov, Arman Abaildayev, Kantemir Satken, Gulzhakhan Utegenova, Ayaz Belkozhayev, Altynay Balmukhanova, Zaure Dzhumatayeva, Ainagul Beissova, Iryna Shargorodska, Aigul Balmukhanova, Kamalidin Sharipov iD

PeerJ · 2025

DOI: 10.7717/peerj.19259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Aizhan Magazova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Circulating MicroRNA, MicroRNAs. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science, Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic retinopathy (DR) is the most common complication of diabetes, leading to blindness. The asymptomatic onset and the existing difficulties in diagnosing warrant the search for biomarkers that can facilitate the early diagnosis of DR. The aim of this study was to evaluate the potential of plasma microRNAs (miRNAs), which have previously been shown to be involved in the pathogenesis of DR and differentially expressed in plasma/serum of patients, as biomarkers for DR in the Kazakhstani population. Materials and Methods Using quantitative RT-PCR, we compared the levels of ten candidate miRNAs in plasma among three groups: type 2 diabetes mellitus (T2DM) patients with DR (DR patients, N = 100), T2DM patients without DR (noDR patients, N = 98), and healthy controls ( N = 30).

Results

Level of miR-423-3p was significantly reduced in DR patients compared to noDR patients ( p FDR = 5.4 × 10 −3 ). Levels of miR-423-3p and miR-221-3p were significantly reduced in DR patients compared to controls ( p FDR = 5.4 × 10 −3 and 0.024, respectively ), level of miR-23a-3p was significantly reduced in noDR patients compared to controls ( p FDR = 0.047), levels of miR-221-3p and miR-23a-3p were significantly reduced in T2DM patients (combined group) compared to controls ( p FDR = 0.047, and 0.049, respectively). Also, there were several significant differences between groups formed based on clinical-pathological characteristics, but none of these results remained significant after adjustment for multiple comparisons. Correlation analysis revealed weak associations between the levels of miR-423 and miR-221-3p and DR staging ( p FDR = 1.3 × 10 −3 and 0.026, respectively), and fair associations between the levels of miR-29b-3p and miR-328-3p and diabetes duration in noDR patients ( p FDR = 8.8 × 10 −3 and 0.016, respectively). According to receiver operating characteristic (ROC) analysis, only miR-23a-3p can be considered a potential biomarker with moderate informativeness for diagnosing proliferative DR (PDR); however, a larger sample size is needed to verify this finding. Furthermore, the small magnitude of observed changes in miRNA levels between groups significantly complicates classification.

Conclusions

Due to the low specificity and small magnitude of deviations from the norm, the studied miRNAs have low potential in the diagnosis of DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2Circulating MicroRNAMicroRNAsHumansMaleFemaleMiddle AgedBiomarkersKazakhstanCase-Control StudiesAgedAdultROC Curve

Stichwörter der Autor:innen

Blood plasma biomarkerCirculating microRNADiabetic retinopathyType 2 diabetes mellitus

Substanzen

BiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty, Kazakhstan.
  • Almaty Multidisciplinary Clinical Hospital, Almaty, Kazakhstan.
  • Department of Ophthalmology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Department of Biology, South Kazakhstan Pedagogical University named after Ozbekali Zhanibekov, Shymkent, Kazakhstan.
  • Department of Chemical and Biochemical Engineering, Geology and Oil-Gas Business Institute named after K. Turyssov, Satbayev University, Almaty, Kazakhstan.
  • Department of Health Policy and Organization, Al-Farabi Kazakh National University, Almaty, Kazakhstan.

ORCID-Profile: Kamalidin Sharipov

Förderung

  • Committee of Science of the Ministry of Science
  • Higher Education of the Republic of Kazakhstan

Zitieren

APA

Magazova, A., Ashirbekov, Y., Abaildayev, A., Satken, K., Utegenova, G., Belkozhayev, A., Balmukhanova, A., Dzhumatayeva, Z., Beissova, A., Shargorodska, I., Balmukhanova, A., & Sharipov, K. (2025). Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan. PeerJ. https://doi.org/10.7717/peerj.19259

Vancouver

Magazova A, Ashirbekov Y, Abaildayev A, Satken K, Utegenova G, Belkozhayev A, et al. Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan. PeerJ. 2025. doi:10.7717/peerj.19259

BibTeX
@article{Magazova2025,
  author = {Magazova, Aizhan and Ashirbekov, Yeldar and Abaildayev, Arman and Satken, Kantemir and Utegenova, Gulzhakhan and Belkozhayev, Ayaz and Balmukhanova, Altynay and Dzhumatayeva, Zaure and Beissova, Ainagul and Shargorodska, Iryna and Balmukhanova, Aigul and Sharipov, Kamalidin},
  title = {Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19259}
}
Kostenlos starten →